| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
PADCEV plus Keytruda is the first and only approved perioperative treatment regimen that can significantly improve survival ove...
Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement wi...
Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.
Saudi Arabia has committed to purchasing hundreds of U.S.-made tanks, underlining an expansive defense and economic partnership...
https://www.bloomberg.com/news/articles/2025-11-18/pfizer-kicks-off-us-dollar-bond-sale-to-help-fund-metsera-deal
Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board ov...
Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com...
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.